No abstract available
MeSH terms
-
Bone Density Conservation Agents* / adverse effects
-
Denosumab / adverse effects
-
Humans
-
Hypocalcemia* / chemically induced
-
Osteoporosis* / chemically induced
-
Osteoporosis* / drug therapy
Substances
-
Bone Density Conservation Agents
-
Denosumab